These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2129802)

  • 1. Ras p21 onco-protein in the sera of mice carrying an experimentally induced tumor and in human cancer patients.
    Kakkanas A; Spandidos DA
    In Vivo; 1990; 4(2):115-20. PubMed ID: 2129802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
    Ward JM; Perantoni AO; Santos E
    Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
    Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse.
    Pullano TG; Sinn E; Carney WP
    Oncogene; 1989 Aug; 4(8):1003-8. PubMed ID: 2474786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated Val-12 ras p21 in cell culture fluids and mouse plasma.
    Hamer PJ; La Vecchio J; Ng S; DeLellis R; Wolfe H; Carney WP
    Oncogene; 1991 Sep; 6(9):1609-15. PubMed ID: 1923528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products.
    Caulín C; López-Barcons L; Gonzáles-Garrigues M; Navarro P; Lozano E; Rodrigo I; Gamallo C; Cano A; Fabra A; Quintanilla M
    Mol Carcinog; 1996 Feb; 15(2):104-14. PubMed ID: 8599577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogene.
    Nielsen LL; Discafani CM; Gurnani M; Tyler RD
    Cancer Res; 1991 Jul; 51(14):3762-7. PubMed ID: 2065330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer.
    Singh J; Hamid R; Reddy BS
    Cancer Res; 1997 Jan; 57(2):253-8. PubMed ID: 9000564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p21 ras oncoproteins in human cancers.
    Tanaka T; Slamon DJ; Battifora H; Cline MJ
    Cancer Res; 1986 Mar; 46(3):1465-70. PubMed ID: 3510727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.
    Muschel RJ; Williams JE; Lowy DR; Liotta LA
    Am J Pathol; 1985 Oct; 121(1):1-8. PubMed ID: 3901774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model.
    Adnane J; Jackson RJ; Nicosia SV; Cantor AB; Pledger WJ; Sebti SM
    Oncogene; 2000 Nov; 19(47):5338-47. PubMed ID: 11103935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EJ/ras neoplastic transformation of simian virus 40-immortalized human uroepithelial cells: a rare event.
    Christian BJ; Kao CH; Wu SQ; Meisner LF; Reznikoff CA
    Cancer Res; 1990 Aug; 50(15):4779-86. PubMed ID: 2164447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harvey-ras mediated neoplastic development in the mouse mammary gland.
    Strange R; Aguilar-Cordova E; Young LJ; Billy HT; Dandekar S; Cardiff RD
    Oncogene; 1989 Mar; 4(3):309-15. PubMed ID: 2784851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth properties and tumorigenesis of MCF-7 cells transfected with isogenic mutants of rasH.
    Sommers CL; Papageorge A; Wilding G; Gelmann EP
    Cancer Res; 1990 Jan; 50(1):67-71. PubMed ID: 2403419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
    Kuo ML; Chou YW; Chau YP; Huang TS
    Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of monoclonal antibodies specific to the activated ras p21 with aspartic acid at position 13.
    La Vecchio JA; Hamer PJ; Ng SC; Trimpe KL; Carney WP
    Oncogene; 1990 Aug; 5(8):1173-8. PubMed ID: 2202949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
    Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different levels of v-Ha-ras p21 expression in primary keratinocytes transformed with Harvey sarcoma virus correlate with benign versus malignant behavior.
    Brissette JL; Missero C; Yuspa SH; Dotto GP
    Mol Carcinog; 1993; 7(1):21-5. PubMed ID: 8435106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.